RESEARCH-USE BIOSIMILAR ANTIBODY
Mecbotamab
Antibody-drug conjugate · IgG1
Mecbotamab is a humanized IgG1-κ antibody targeting to AXL receptor tyrosine kinase (AXL). Mecbotamab can serves as a conditionally active biologic (CAB), which can be conjugated with MMAE (HY-15162) via a cleavable linker, to form ADC Mecbotamab vedotin (BA3011).
TARGETAXL
YAntibody-drug conjugate
CATALOGSC-BS-380
CATALOG NUMBERSC-BS-380
MOLECULAR WEIGHTApprox. 145.126 kDa
PRODUCT FORMATAntibody-drug conjugate
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Mecbotamab is a humanized IgG1-κ antibody targeting to AXL receptor tyrosine kinase (AXL). Mecbotamab can serves as a conditionally active biologic (CAB), which can be conjugated with MMAE (HY-15162) via a cleavable linker, to form ADC Mecbotamab vedotin (BA3011).
Mecbotamab is a recombinant research-use antibody directed against AXL.